Related references
Note: Only part of the references are listed.A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus
Michael Schwendinger et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Donor Cytomegalovirus Transmission Patterns in Solid Organ Transplant Recipients With Primary Infection
Maria E. Hasing et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus
Virginia-Maria Vlahava et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients
Philip Vutien et al.
LIVER TRANSPLANTATION (2021)
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2020)
Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events
Sara Gianella et al.
AIDS (2020)
The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccination
Paul Griffiths
ANTIVIRAL RESEARCH (2020)
Choice of Study Populations for Vaccines
Paul Griffiths et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors A Randomized Clinical Trial
Nina Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Whole-Genome Approach to Assessing Human Cytomegalovirus Dynamics in Transplant Patients Undergoing Antiviral Therapy
Nicolas M. Suarez et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Why the elderly appear to be more severely affected byCOVID-19: The potential role of immunosenescence andCMV
Seilesh Kadambari et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Modulation of innate and adaptive immunity by cytomegaloviruses
Richard Berry et al.
NATURE REVIEWS IMMUNOLOGY (2020)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Francisco M. Marty et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Theresa Kaeuferle et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Generation, maintenance and tissue distribution of T cell responses to human cytomegalovirus in lytic and latent infection
Sarah E. Jackson et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2019)
OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism
E. Xiaofei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis
Mohamed Zuhair et al.
REVIEWS IN MEDICAL VIROLOGY (2019)
Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis
Ajit P. Limaye et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene Loss
Nicolas M. Suarez et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
Genovefa A. Papanicolaou et al.
CLINICAL INFECTIOUS DISEASES (2019)
A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients
Deepali Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Criteria to define interruption of transmission of human cytomegalovirus from organ donor to recipient
Ilona Anna Baraniak et al.
REVIEWS IN MEDICAL VIROLOGY (2018)
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia
Ilona Baraniak et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2018)
CD147 Promotes Entry of Pentamer-Expressing Human Cytomegalovirus into Epithelial and Endothelial Cells
Adam L. Vanarsdall et al.
MBIO (2018)
An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor
Nadia Martinez-Martin et al.
CELL (2018)
HCMV-Encoded NK Modulators: Lessons From in vitro and in vivo Genetic Variation
Mihil Patel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism
Christopher C. Nguyen et al.
VIRUSES-BASEL (2018)
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis
Yoichiro Natori et al.
CLINICAL INFECTIOUS DISEASES (2018)
Navigating the Host Cell Response during Entry into Sites of Latent Cytomegalovirus Infection
Matthew J. Murray et al.
PATHOGENS (2018)
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
Julie H. Ishida et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2017)
Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness A Randomized Clinical Trial
Ajit P. Limaye et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients
Yupin Tong et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia
Michael Boeckh et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Characterization of Human Cytomegalovirus Genome Diversity in Immunocompromised Hosts by Whole-Genome Sequencing Directly From Clinical Specimens
Elias Hage et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Transient Oral Human Cytomegalovirus Infections Indicate Inefficient Viral Spread from Very Few Initially Infected Cells
Bryan T. Mayer et al.
JOURNAL OF VIROLOGY (2017)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation
Ceri A Fielding et al.
eLife (2017)
Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells
Sarah E. Jackson et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cytomegalovirus, Epstein-Barr virus and varicella zoster virus infection in the first two years of life: a cohort study in Bradford, UK
Lucy Pembrey et al.
BMC INFECTIOUS DISEASES (2017)
Cytomegalovirus latency and reactivation: recent insights into an age old problem
Liane Dupont et al.
REVIEWS IN MEDICAL VIROLOGY (2016)
A new perspective of the structural complexity of HCMV-specific T-cell responses
Andrew Sylwester et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2016)
Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants
E. Panagou et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
Human Cytomegalovirus Latency: Approaching the Gordian Knot
Felicia Goodrum
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Islands of linkage in an ocean of pervasive recombination reveals two-speed evolution of human cytomegalovirus genomes
Florent Lassalle et al.
VIRUS EVOLUTION (2016)
High-Throughput Analysis of Human Cytomegalovirus Genome Diversity Highlights the Widespread Occurrence of Gene-Disrupting Mutations and Pervasive Recombination
Steven Sijmons et al.
JOURNAL OF VIROLOGY (2015)
Sepsis and cytomegalovirus: foes or conspirators?
Sara Mansfield et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
Limits and patterns of cytomegalovirus genomic diversity in humans
Nicholas Renzette et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D plus R plus liver transplant patients
Ellen Van Damme et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Diverse Specificities, Phenotypes, and Antiviral Activities of Cytomegalovirus-Specific CD8+ T Cells
S. E. Jackson et al.
JOURNAL OF VIROLOGY (2014)
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
Roy F. Chemaly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients
Elisa Gabanti et al.
PLOS ONE (2014)
Seropositivity and Higher Immunoglobulin G Antibody Levels Against Cytomegalovirus Are Associated With Mortality in the Population-Based European Prospective Investigation of Cancer-Norfolk Cohort
Effrossyni Gkrania-Klotsas et al.
CLINICAL INFECTIOUS DISEASES (2013)
Complex Correlates of Protection After Vaccination
Stanley A. Plotkin
CLINICAL INFECTIOUS DISEASES (2013)
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
Francisco M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Seroprevalence of Cytomegalovirus, Epstein Barr Virus and Varicella Zoster Virus among Pregnant Women in Bradford: A Cohort Study
Lucy Pembrey et al.
PLOS ONE (2013)
Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
S. F. Atabani et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
Mohamed A. Kharfan-Dabaja et al.
LANCET INFECTIOUS DISEASES (2012)
Decoding Human Cytomegalovirus
Noam Stern-Ginossar et al.
SCIENCE (2012)
Human Cytomegalovirus Encoded Homologs of Cytokines, Chemokines and their Receptors: Roles in Immunomodulation
Brian P. McSharry et al.
VIRUSES-BASEL (2012)
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Per Ljungman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Inhibition of Inflammatory Interleukin-6 Activity via Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase Signaling Antagonizes Human Cytomegalovirus Reactivation from Dendritic Cells
Matthew B. Reeves et al.
JOURNAL OF VIROLOGY (2011)
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
Paul D. Griffiths et al.
LANCET (2011)
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Francisco M. Marty et al.
LANCET INFECTIOUS DISEASES (2011)
Seropositivity to Cytomegalovirus, Inflammation, All-Cause and Cardiovascular Disease-Related Mortality in the United States
Amanda M. Simanek et al.
PLOS ONE (2011)
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
Tobias Feuchtinger et al.
BLOOD (2010)
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication
Richard J. Stanton et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112
Virginie Prod'homme et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Experimental human cytomegalovirus latency in CD14+ monocytes
Danna Hargett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications
M. Grazia Revello et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
Drew J. Winston et al.
BLOOD (2008)
Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection
Daniele Lilleri et al.
HAEMATOLOGICA (2008)
Cytomegalovirus seroprevalence and childhood sources of infection: A population-based study among pre-adolescents in the United States
Stephanie A. S. Staras et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects
Mary K. Wloch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988-1994
Stephanie A. S. Staras et al.
SEXUALLY TRANSMITTED DISEASES (2008)
Incidence of cytomegalovirus infection among the general population and pregnant women in the United States
Fernando A. B. Colugnati et al.
BMC INFECTIOUS DISEASES (2007)
The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- cells
Virginie Prod'homme et al.
JOURNAL OF IMMUNOLOGY (2007)
Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism
D Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Washing our hands of the congenital cytomegalovirus disease epidemic
MJ Cannon et al.
BMC PUBLIC HEALTH (2005)
Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers
MB Reeves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141
P Tomasec et al.
NATURE IMMUNOLOGY (2005)
T cells and viral persistence: lessons from diverse infections
P Klenerman et al.
NATURE IMMUNOLOGY (2005)
Genetic content of wild-type human cytomegalovirus
A Dolan et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
C Paya et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
M Boeckh et al.
BLOOD (2004)
Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis
AP Limaye et al.
TRANSPLANTATION (2004)
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy
JR Deayton et al.
LANCET (2004)
Functional profiling of a human cytomegalovirus genome
W Dunn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome
JH Kempen et al.
CLINICAL INFECTIOUS DISEASES (2003)
Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products
KG Nichols et al.
BLOOD (2003)
Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers
R Elkington et al.
JOURNAL OF VIROLOGY (2003)
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcγ receptor homologs
R Atalay et al.
JOURNAL OF VIROLOGY (2002)
Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts
VC Emery et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease
RR Razonable et al.
TRANSPLANTATION (2002)
Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein
BN Lilley et al.
JOURNAL OF VIROLOGY (2001)
Quantity of cytomegalovirus DNA in different leukocyte populations during active infection in vivo and the presence of gB and UL18 transcripts
AF Hassan-Walker et al.
JOURNAL OF MEDICAL VIROLOGY (2001)
ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
D Cosman et al.
IMMUNITY (2001)
Encouraging prospects for immunisation against primary cytomegalovirus infection
PD Griffiths et al.
VACCINE (2001)
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants
AP Limaye et al.
LANCET (2000)
Share Paper
